Author:
Li Dan,Dong Kaifeng,Su Jing,Xue Haitao,Tian Junhai,Wu Yongfeng,Wang Jingtian
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference73 articles.
1. MYCT1 inhibits the EMT and migration of laryngeal cancer cells via the SP1/miR-629-3p/ESRP2 pathway;Yue;Cell Signal,2020
2. Multifunctional zinc metal–organic framework for highly selective detection of picric acid and inhibition of laryngeal cancer cell growth;Wu;J Cluster Sci,2020
3. Five genes as a novel signature for predicting the prognosis of patients with laryngeal cancer;Zhang;J Cell Biochem,2020
4. Cost-effectiveness of surgery versus organ preservation in advanced laryngeal cancer: CEA laryngectomy vs. organ preservation;Beck;Laryngoscope,2020
5. Jamshed A: Incidence of thyroid gland invasion in advanced laryngeal cancers and its impact on disease-specific survival; a retrospective review at a tertiary care center;Faisal;Acta Otolaryngol,2020